Assisted Reproductive Technology (ART) Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Growth Factors of Assisted Reproductive Technology Market

Assisted Reproductive Technology (ART) encompasses a range of medical procedures designed taddress infertility challenges, enabling individuals and couples tconceive. Techniques such as In-VitrFertilization (IVF), Artificial Insemination (AI-IUI), and Frozen EmbryTransfer (FET) have become integral treproductive healthcare. The global ART market has witnessed significant growth, driven by various factors influencing its expansion and adoption.

Market Overview and Growth Projections

In 2018, the global ART market was valued at USD 21.32 billion. Projections indicate a substantial growth trajectory, with expectations treach USD 45.06 billion by 2026, reflecting a Compound Annual Growth Rate (CAGR) of 9.8% during the forecast period.

This growth is attributed tthe increasing prevalence of infertility, advancements in reproductive technologies, and supportive governmental initiatives.

Key Drivers of Market Growth

1. Rising Infertility Rates: Lifestyle changes, stress, and delayed family planning have contributed thigher infertility rates globally. For instance, in the United States, approximately 6.7% of women aged 15 t44 experienced infertility in 2018.

Similarly, in the United Kingdom, one in ten men aged 16 t74 has faced infertility issues.

2. Technological Advancements: Innovations such as Intracytoplasmic Sperm Injection (ICSI) and time-lapse imaging systems have improved success rates of ART procedures, making them more accessible and effective.

3. Government Initiatives: Various governments and non-profit organizations are actively supporting fertility treatments, aiming tprovide affordable options for individuals and couples seeking assistance. These initiatives are crucial in reducing the socio-ethical stigma associated with ART procedures.

Segmentation of the ART Market

• By Technique:

In-VitrFertilization (IVF): Dominates the market due tits high success rates and continuous technological improvements.

Artificial Insemination (AI-IUI) and Frozen EmbryTransfer (FET): Alscontribute significantly, with FET offering cost-effective solutions and opportunities for repeated attempts.

• By Procedure:

Fresh Non-donor: Expected texhibit high growth owing thigher success rates associated with fresh embryos or eggs.

Frozen Non-donor: Preferred for its cost-effectiveness compared tcycles using fresh embryos.

• By End User:

Fertility Clinics: Hold a dominant share due tspecialized services and increasing number of procedures. The presence of skilled professionals and advanced technologies in these clinics enhances patient outcomes.

Hospitals: Account for a smaller market share, attributed tlower adoption of advanced techniques and limited specialized services.

Regional Insights

• Europe: Led the global ART market with a 41.18% share in 2018, driven by high infertility rates and demand for ART procedures. Countries like Spain, Denmark, the UK, Germany, and France are particularly active in fertility services.
• North America: Expected texperience significant growth due thigher adoption of advanced services and increasing disposable incomes. The U.S. has seen a notable rise in ART procedures, contributing tmarket expansion.
• Asia Pacific: Projected tregister a higher CAGR by 2026, attributed trising infertility rates and reduced socio-ethical stigma. Emerging markets in China, Australia, and Japan are contributing tthis growth.

Challenges and Restraints

Despite the positive outlook, the ART market faces challenges, including high treatment costs and socio-ethical concerns. According tthe World Health Organization (WHO), many women in emerging countries cannot afford infertility treatments due ttheir high costs.

Additionally, societal perceptions and ethical debates surrounding ART procedures may hinder market growth in certain regions.

Future Outlook

The ART market is poised for substantial growth, supported by technological advancements, increasing awareness, and supportive policies. Key players are focusing on expanding their service portfolios and geographical presence tcater tthe growing demand. For example, Monash IVF Group acquired Fertility Solutions in July 2019 tenhance its global footprint.

Such strategic initiatives are expected tdrive the market forward, making ART services more accessible and effective for individuals and couples worldwide.

In conclusion, the Assisted Reproductive Technology market is experiencing dynamic growth, influenced by a combination of medical, technological, and societal factors. Addressing challenges related tcost and ethical perceptions will be crucial in ensuring that ART services can meet the needs of those seeking reproductive assistance globally.

ATTRIBUTE DETAILS

Study Period - 2015-2026

Base Year - 2018

Forecast Period - 2019-2026

Historical Period - 2015-2017

Unit - Value (USD billion)

Segmentation By Technique

• In VitrFertilization (IVF)
• Artificaial Insemination (AI-IUI)
• Frozen EmbryTransfer (FET)
• Others

By Procedure

• Fresh Donor
• Fresh Non-donor
• Frozen Donor
• Frozen Non-donor

By End User

• Hospitals
• Fertility Clinics

By Geography

• North America (U.S. and Canada)
• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
• Latin America (Brazil, Mexico, and Rest of Latin America)
• Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Please Note: It will take 5-6 business days to complete the report upon order confirmation.